Ge Zhi is still in Singapore fighting extradition to the US and is yet to enter a plea. Read more at straitstimes.com.

WASHINGTON] An alleged international insider trading conspiracy that US officials say yielded millions of dollars in illegal ...

WASHINGTON] An alleged international insider trading conspiracy that US officials say yielded millions of dollars in illegal ...

Frederic Arnault, one of the five children of LVMH chairman and CEO Bernard Arnault, will become chief executive of the group ...

Swiss drugmaker Novartis is ending its use of diverse panels for all of its hiring in the United States, the company told ...

The Kooyong Classic has welcomed tennis legend and former Wimbledon champion Pat Cash as an official ambassador for the ...

Q4 2024 Earnings Call Transcript March 7, 2025 Operator: Good morning, and welcome to the Molecular Partners Fourth Quarter and Full Year 2024 Results Call. All participants will be in listen-only ...

It has a strategic collaboration with Biogen for the treatment of neurological disorders; and collaboration and license agreement with GSK, AstraZeneca, Novartis, and Roche, as well as with ...

Genmab A/S, a biotechnology company, develops antibody-based products and product candidates for the treatment of cancer and other diseases in Denmark. The company markets EPKINLY and TEPKINLY for ...

Novartis (NVS) announced that oral Fabhalta, iptacopan, has received U.S. Food and Drug Administration approval for the ...

Novartis’s (NVS) parasite-selective proteasome inhibitor with potent activity against kinetoplastid parasites was granted FDA orphan ...

Novartis NVS announced that the FDA has approved Fabhalta (iptacopan) for a third indication. The regulatory body approved the drug for the treatment of adults with C3 glomerulopathy (C3G) to ...